{"title":"Studies on U50,488H-induced increases in serum corticosterone level and diuresis in wildtype and mutant mice expressing phosphorylation-deficient kappa opioid receptor.","authors":"Pingwei Zhao, Peng Huang, Kathryn Bland, Sanjana Khandeshi, Lee-Yuan Liu-Chen","doi":"10.3389/adar.2026.17289","DOIUrl":"10.3389/adar.2026.17289","url":null,"abstract":"<p><p>We previously showed that mice expressing a phosphorylation-deficient kappa opioid receptor mutant (K4A) exhibited reduced U50,488H-induced anti-scratching tolerance in males and reduced conditioned place aversion in females, without changes in acute anti-scratching or hypo-locomotor effects. Here, we examined whether K4A mutations, which markedly diminish β-arrestin-mediated signaling, alter U50,488H-induced increases in serum corticosterone and urine output. K4A and wildtype mice received U50,488H (5 mg/kg, s.c.) or saline. Blood was collected 1 h later and serum corticosterone was measured by ELISA. Urine was collected for 1 h beginning 10 min after injection. U50,488H increased serum corticosterone to similar levels in wildtype and K4A mice of both sexes. U50,488H and nalfurafine enhanced serum corticosterone to similar extents in wildtype mice. Basal corticosterone levels were higher in females than males regardless of genotype. U50,488H significantly increased urine output in both sexes, with no genotype differences. The net increase in urine output was greater in males than females. Thus, KOR phosphorylation and associated β-arrestin-mediated signaling are not required for U50,488H-induced increases in serum corticosterone or diuresis in either sex. These findings also demonstrate, for the first time, that KOR activation produces greater diuresis in male than female mice.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"17289"},"PeriodicalIF":0.0,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chemsex and its implications for human immunodeficiency virus risk, testing, and prevention among men who have sex with men in Hong Kong.","authors":"Alex Siu Wing Chan","doi":"10.3389/adar.2026.16956","DOIUrl":"10.3389/adar.2026.16956","url":null,"abstract":"","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16956"},"PeriodicalIF":0.0,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The prison-to-community transition as a neuropeptide stress test: an allostatic continuity agenda for addiction care.","authors":"Aina Afini Abd Basir, Zalmizy Hussin","doi":"10.3389/adar.2026.17562","DOIUrl":"https://doi.org/10.3389/adar.2026.17562","url":null,"abstract":"","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"17562"},"PeriodicalIF":0.0,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13713434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Susan M Greene, Gloria-Andrea Alcala, Blanka Bordas, Vy Vu, Yatzil Sanchez, Angela Ontanon, Georgianna G Gould
{"title":"Acute metformin treatment increased social sniffing in male but not female BTBR mice.","authors":"Susan M Greene, Gloria-Andrea Alcala, Blanka Bordas, Vy Vu, Yatzil Sanchez, Angela Ontanon, Georgianna G Gould","doi":"10.3389/adar.2026.16883","DOIUrl":"10.3389/adar.2026.16883","url":null,"abstract":"<p><p>Autism spectrum disorders (ASDs) are characterized by social deficits and restrictive-repetitive behaviors. Metformin has recently been investigated for its potential behavioral effects in ASD models. This study examined the acute effects of metformin on social interaction preferences and marble burying in male and female BTBR T + Itpr3tf/J (BTBR) mice, with C57BL/6J and 129S1/SvImJ mice included as strain controls. The mice received a single intraperitoneal injection of metformin (0 mg, 75 mg, or 150 mg/kg), and the effects were compared using three-chamber social preference and marble burying tests. Acute metformin increased not only social interaction preferences, as determined by differences in time spent in chambers, but also by differences in social sniffing time in male BTBR mice at 150 mg/kg. Surprisingly, it did not alter sociability preferences in BTBR females or in C57BL/6J or 129S1/SvImJ mice. In C57BL/6J females, metformin reduced chamber entries and marble burying, whereas males were unaffected. Progesterone and corticosterone levels were measured in BTBR and C57BL/6J serum collected after behavioral testing, and their levels were unaffected by metformin treatment. These findings indicate that metformin acutely produces modest, beneficial behavioral effects in male BTBR mice, which otherwise exhibit social interaction deficits that are translationally relevant to ASD.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16883"},"PeriodicalIF":0.0,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13696365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samuel Habimana, Zephon Lister, Emmanuel Biracyaza, Aflodis Kagaba, Albert Ndagijimana, Stefan Jansen, Eugene Rutembesa, Susanne Montgomery
{"title":"Profile of risk factors for people who inject drugs among a sample at high risk of HIV/AIDS in Kigali, Rwanda.","authors":"Samuel Habimana, Zephon Lister, Emmanuel Biracyaza, Aflodis Kagaba, Albert Ndagijimana, Stefan Jansen, Eugene Rutembesa, Susanne Montgomery","doi":"10.3389/adar.2026.16156","DOIUrl":"10.3389/adar.2026.16156","url":null,"abstract":"<p><strong>Background: </strong>The increasing prevalence of people who inject drugs (PWID) among populations at high risk for human immunodeficiency virus (HIV) has become a critical public health concern, particularly in Africa. This issue is associated with substantial health-related effects among populations at high risk for HIV/AIDS. Hence, our study aimed to analyze the associations between sociodemographic characteristics, alcohol and substance dependence, and depressive symptoms among populations at high risk for HIV.</p><p><strong>Methods: </strong>We conducted a cross-sectional study with 480 respondents living in Kigali, Rwanda, who self-identified as being at high risk for HIV/AIDS and were recruited via snowball sampling. Chi-square bivariate analyses were used to explore associations with PWID status. Variables that were significant in the bivariate analyses were included in a multivariate logistic regression model, in which adjusted odds ratios were used to determine factors associated with PWID status. A 95% confidence interval and a 5% significance level were used to evaluate statistical associations.</p><p><strong>Results: </strong>Of the 480 respondents, 86.25% reported symptoms of depression, and 31.5% were identified as PWID. Notably, 78% were male and were between 18 years and 45 years of age. Multivariate regression analysis revealed that participants with substance dependence [aOR = 3.547; 95% CI (1.159-10.857)] and those who used marijuana [aOR = 3.261; 95% CI (1.380-7.708)] were more likely to be PWID than their counterparts. Furthermore, individuals with depressive symptoms [aOR = 4.50; 95% CI (2.55-7.96), p = 0.018] were also more likely to be PWID than their counterparts.</p><p><strong>Conclusion: </strong>The results of this study indicated that substance use and alcohol-related behaviors, as well as mental health concerns such as depressive symptoms, were significantly associated with injecting drug use. The findings support the promotion of harm-reduction and prevention strategies that incorporate mental health programs for populations at high risk for HIV.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16156"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13679292/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Berhanu Kibret, Emmanuel S Onaivi, Venkatanarayanan Sharma
{"title":"Distinct contributions of mu opioid and CB2 cannabinoid receptors to neuroimmune and behavioral responses.","authors":"Berhanu Kibret, Emmanuel S Onaivi, Venkatanarayanan Sharma","doi":"10.3389/adar.2026.16646","DOIUrl":"10.3389/adar.2026.16646","url":null,"abstract":"<p><p>Marijuana (cannabis) and cannabinoids are getting global medical and recreational approvals in this era of the opioid epidemic. Both opiates and cannabis are often co-abused, and their use increases the risk of opioid and cannabis use disorders (OUDs and CUDs), and dependency. Opioid and cannabinoid systems share many neuromodulating and pharmacological effects by activating opioid and cannabinoid receptors, respectively. Inflammation is increasingly implicated in many diseases, and mu-opioid receptor (MOR) and CB2 cannabinoid receptor (CB2R) have been linked to neuroinflammation. The hypothesis that changes in MOR and CB2R mediated behavioral and cytokine alterations are associated with their roles in inflammation was tested here. Naïve male C57Bl/6J as wild type, MOR KO mice with deletion of MOR, DAT-<i>Cnr2</i> cKO mice with deletion of CB2R from dopamine neurons and CX3Cr1-<i>Cnr2</i> cKO mice with deletion of CB2R from microglia were used in the study. Nociception was assessed using tail-flick latency, followed by ELISA to quantify levels of cytokines and chemokines in the cerebellum and prefrontal cortex (PFC) regions of the animals. MOR KO, DAT-<i>Cnr2</i>, and CX3Cr1-<i>Cnr2</i> conditional knockout mice exhibited distinct behavioral and neuroimmune phenotypes, marked by genotype- and region-specific alterations in cytokines and chemokine. CX3Cr1-<i>Cnr2</i> cKO mice had reduced tail-flick sensitivity compared to MOR KO, DAT-<i>Cnr2</i> cKO, and wild-type controls. These findings suggest that MOR deletion and cell-specific loss of CB2Rs in dopamine neurons or microglia distinctly affect nociceptive functions, alongside immune signaling changes. Targeting components of the eCBome and opioid systems may offer novel therapeutic strategies for inflammation-linked chronic pain.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16646"},"PeriodicalIF":0.0,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13461565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148727376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shiwani Thapa, Steven Mysiewicz, Alex M Dopico, Anna N Bukiya
{"title":"Cholesterol and docosahexaenoic acid likely protect against alcohol-induced constriction of cerebral arteries via a common pathway.","authors":"Shiwani Thapa, Steven Mysiewicz, Alex M Dopico, Anna N Bukiya","doi":"10.3389/adar.2026.16302","DOIUrl":"10.3389/adar.2026.16302","url":null,"abstract":"<p><p>Binge alcohol drinking is significantly associated with an increased risk of cerebrovascular dysfunction. Within cerebral artery smooth muscle, alcohol inhibits calcium- and voltage-gated potassium (BK) channels of large-conductance, leading to cerebrovascular constriction. Administration of high-cholesterol diet or docosahexaenoic acid (DHA) supplementation independently protects against alcohol-induced constriction of cerebral arteries. However, whether these interventions act additively or through a shared mechanism(s) remains unclear. Here, we examined the combined effects of cholesterol and DHA dietary supplementation <i>in vivo</i> and their combined administration <i>ex vivo</i> on alcohol-induced changes in rat cerebral artery diameter. DHA dietary supplementation <i>in vivo</i> and application to rat cerebral arteries <i>ex vivo</i> did not further modify protective action of high-cholesterol diet and cholesterol-enrichment, respectively. Lack of additivity may point to a shared mechanism(s) that drives cholesterol- and DHA-driven protection against alcohol constriction of cerebral arteries. Considering a prior report of BK channel α-subunit (slo1) residue tyrosine 450 mediating cholesterol protection against alcohol cerebrovascular action, we probed slo1Y450 role in DHA protection against alcohol effect on cerebral artery diameter. DHA protection against alcohol-induced constriction vanished in cerebral arteries harvested from male slo1Y450F knock-in mice. Yet DHA protection against alcohol was still present in arteries harvested from female slo1Y450F knock-in mice. Combined with previous observations, our current findings identify slo1Y450 as a potentially shared target involved in a sexually dimorphic pathway between alcohol effect on cerebral artery diameter and its sensitivity to cholesterol- and DHA-driven interventions.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16302"},"PeriodicalIF":0.0,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13423736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148655033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ariana M Albanese, E Ruby Cramer, Hannah E Frank, Brooke G Rogers
{"title":"Identifying an initial set of core components for perinatal cannabis use harm reduction counseling: An application of the Consensus on Relevant Elements (CORE) process.","authors":"Ariana M Albanese, E Ruby Cramer, Hannah E Frank, Brooke G Rogers","doi":"10.3389/adar.2026.15935","DOIUrl":"10.3389/adar.2026.15935","url":null,"abstract":"<p><p>Cannabis use during pregnancy or lactation is a key topic in healthcare today. It is recommended that patients abstain from perinatal use and healthcare providers are encouraged to discuss use with patients. However, some perinatal individuals continue to use even once educated about the risks. For them, a nuanced approach to counseling that goes beyond warnings of risks is required to promote health and maintain trust. Harm reduction, which views any reduction in harm as a clinical success, is the best evidence-based practice for these patients. However, the essential elements (core components) of this approach have not yet been identified. This limits the approach's readiness for wider implementation, as it is critical that essential elements are maintained during intervention adaptation and scaling. We used the Consensus on Relevant Elements process to generate an initial list of core components for harm reduction counseling of cannabis using-pregnant and breast-feeding patients. We identified five core components within two domains. Within the domain of provider training, the provider 1) is skilled at facilitating conversation, and 2) is educated about cannabis use. Within the domain of patient-facing work, the provider 3) educates patients about cannabis safety and recommendations, 4) screens for cannabis, and 5) provides a brief harm reduction intervention. Future work to achieve a broader consensus of the core components of this approach should be undertaken to confirm these findings. This work serves as an important first step towards equipping healthcare providers to promote health for perinatal cannabis-using patients.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"15935"},"PeriodicalIF":0.0,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13111171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nadine Heckel, Carlos Nordt, Etna J E Engeli, Patricia Dürler, Marcus Herdener
{"title":"A two-factor structure for cannabis use disorder identification test and its associations with demographic factors and cannabis use motives.","authors":"Nadine Heckel, Carlos Nordt, Etna J E Engeli, Patricia Dürler, Marcus Herdener","doi":"10.3389/adar.2026.16094","DOIUrl":"10.3389/adar.2026.16094","url":null,"abstract":"<p><strong>Introduction: </strong>Cannabis use is linked to the risk of developing a Cannabis Use Disorder (CUD), which can often be chronic. Early identification of problematic cannabis use is crucial to lower the risk of CUD and associated adverse effects. However, the factor structure of the widely used Cannabis Use Disorder Identification Test (CUDIT) remains ambiguous. Furthermore, the impact of age and gender on CUD assessed with CUDIT is unknown. Exploring cannabis use motives has been proposed to better understand susceptibility to CUD. This study aims to clarify the CUDIT's factor structure, its links to cannabis use motives, and the influence of age and gender on CUD.</p><p><strong>Materials and methods: </strong>We analyzed data from 3454 people who use cannabis (20.5% women; mean age = 30.31 years), collected from a Swiss online survey. Participants were categorized into four groups: younger men, younger women, older men, older women. Principal Component Analysis and Confirmatory Factor Analysis tested the factor structure of the revised CUDIT version (CUDIT-R). Structural Equation Modeling explored whether the influence of use motives on the CUDIT-R factors differs between demographic groups.</p><p><strong>Results: </strong>The results suggest that the CUDIT-R scale is best represented by two factors: Use Intensity (Cronbach's <math><mrow><mi>α</mi></mrow> </math> = 0.71) and Awareness of Problematic Use (Cronbach's <math><mrow><mi>α</mi></mrow> </math> = 0.72). Use Intensity was lowest for younger women, and younger participants were more aware of negative effects. Gender, age, and use motives uniquely relate with both CUDIT-R factors, highlighting the CUDIT-R's potential to guide early identification and treatment of individuals at risk for CUD.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"16094"},"PeriodicalIF":0.0,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12989445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Molecular and biochemical correlates of frontal lobe white matter degeneration in humans with alcohol use disorder.","authors":"Suzanne M de la Monte, Ming Tong, Greg Sutherland","doi":"10.3389/adar.2026.15431","DOIUrl":"10.3389/adar.2026.15431","url":null,"abstract":"<p><strong>Background: </strong>Alcohol-related brain damage caused by heavy alcohol misuse is associated with cognitive-motor impairment and white matter (WM) degeneration. Oligodendrocytes and myelin are major targets, but the underlying mechanisms remain incompletely characterized, particularly in humans.</p><p><strong>Purpose: </strong>This study investigates the nature of oligodendrocyte dysfunction in anterior frontal lobe tissue from humans with alcohol use disorder (AUD), focusing on molecular and biochemical pathologies that may underlie WM ARBD.</p><p><strong>Methods: </strong>Cores of fresh frozen human postmortem frontal lobe WM from adults with AUD or no history of substance use disorder (N = 6/group) were analyzed with duplex enzyme-linked immunosorbent assays, multiplex immunoassays, and multiplex RNA hybridization panels.</p><p><strong>Results: </strong>AUD anterior frontal lobe WM tissue exhibited myelin loss with significant changes in oligodendrocyte/myelin glycoprotein immunoreactivity and mRNA expression, increased glial fibrillary acidic protein, and reduced expression of mRNA transcripts encoding upstream components of the insulin and insulin-like growth factor networks, aspartyl-asparaginyl-β-hydroxylase, and the Notch signaling pathway. In contrast, neuroinflammatory mediators and Alzheimer's disease (AD) biomarkers were largely unaffected.</p><p><strong>Conclusion: </strong>Human AUD anterior frontal lobe WM pathology is accompanied by significant alterations in oligodendrocyte and astrocyte function, with alterations in Notch and insulin/IGF signaling. The findings provide new information on the mechanisms of AUD-mediated WM degeneration as well as potential strategies for diagnosing ARBD in humans.</p>","PeriodicalId":72092,"journal":{"name":"Advances in drug and alcohol research","volume":"6 ","pages":"15431"},"PeriodicalIF":0.0,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147437946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}